Examining the latent structure of negative symptoms: Is there a distinct subtype of negative symptom schizophrenia?

被引:81
|
作者
Blanchard, JJ [1 ]
Horan, WP
Collins, LM
机构
[1] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
schizophrenia; negative symptoms; deficit syndrome; taxometrics;
D O I
10.1016/j.schres.2005.03.022
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Negative symptoms have emerged as a replicable factor of symptomatology within schizophrenia. Although rating scales provide assessments along dimensions of severity, categorization into a negative symptom subtype is typically conducted. A categorical view of negative symptoms is best reflected in the proposal that enduring, primary negative symptoms, or deficit symptoms, reflect a distinct subtype of schizophrenia [Carpenter, W.T., Heinrichs, D.W., Wagman, A.M.I., 1988. Deficit and nondeficit forms of schizophrenia: The concept. Am. J. Psychiatry 145, 578-583.]. Despite an accumulation of findings that support a categorical conceptualization, the data are also consistent with a dimensional-only model where negative symptom subtypologies simply reflect an extreme on a continuum of severity. Using taxometric statistical methods [Waller, N.G., Meehl, P.E., 1998. Multivariate Taxometric Procedures: Distinguishing Types From Continua. Sage, Newbury Park, CA.], the present study examined whether a taxonic, or latent class, model best describes negative symptoms in a sample of 238 schizophrenia patients. In order to obtain more stable estimates of symptoms, ratings on the Scale for the Assessment of Negative Symptoms [Andreasen, N.C., 1982. Negative symptoms in schizophrenia: Definition and reliability. Arch. Gen. Psychiatry 39, 784-788.] were averaged across two assessments over a 6-month period. Two taxomettic methods, maximum covariance analysis (MAXCOV) and mean above minus below a cut (MAMBAC) identified a latent class or taxon with a base rate of approximately 28-36%. Members of the negative symptom taxon differed from the nontaxon class in that taxon members were more likely to be male and demonstrated poorer social functioning. Taxon and nontaxon schizophrenia patients did not differ in psychotic or affective symptoms. The findings converge to provide support for a categorical view of negative symptoms. Further research is required to replicate the present taxonic findings and to examine characteristics (including possible etiological factors) associated with this negative symptom taxon. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 165
页数:15
相关论文
共 50 条
  • [41] Learning the Affective Value of Others in Schizophrenia: Examining the Role of Negative Symptoms and Cognitive Deficits
    Kristen R. Dwyer
    Melanie E. Bennett
    Jack J. Blanchard
    Journal of Psychopathology and Behavioral Assessment, 2020, 42 : 714 - 724
  • [42] Transcranial magnetic stimulation (rTMS) and negative symptoms of schizophrenia
    Brunelin, J.
    Poulet, E.
    Bor, J.
    Rivet, A.
    Eche, J.
    d'Amato, T.
    Saoud, M.
    ANNALES MEDICO-PSYCHOLOGIQUES, 2010, 168 (06): : 422 - 427
  • [43] The longitudinal course of schizophrenia: testosterone and progression of the negative symptoms
    Sisek-Sprem, Mirna
    Gradiski, Ivan Pavao
    Zaja, Nikola
    Herceg, Miroslav
    NORDIC JOURNAL OF PSYCHIATRY, 2020, 74 (02) : 147 - 154
  • [44] Psychopathological aspects of negative symptoms in schizophrenia
    Cermolacce, M.
    Belzeaux, R.
    Pringuey, D.
    Adida, M.
    Azorin, J. -M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2015, 41 : 6S9 - 6S14
  • [45] No Effects of Antidepressants on Negative Symptoms in Schizophrenia
    Hinkelmann, Kim
    Yassouridis, Alexander
    Kellner, Michael
    Jahn, Holger
    Wiedemann, Klaus
    Raedler, Thomas J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (05) : 686 - 690
  • [46] The Effects of Bupropion on Negative Symptoms in Schizophrenia
    Yassini, Mojtaba
    Shariat, Neda
    Nadi, Mohammad
    Amini, Fariba
    Vafaee, Mohammad
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (04): : 1227 - 1233
  • [47] NEUROLEPTIC TREATMENT AND NEGATIVE SYMPTOMS IN DEFICIT AND NONDEFICIT SCHIZOPHRENIA
    BUSTILLO, JR
    KIRKPATRICK, B
    BUCHANAN, RW
    BIOLOGICAL PSYCHIATRY, 1995, 38 (01) : 64 - 67
  • [48] The structure of negative symptoms within schizophrenia: Implications for assessment
    Blanchard, JJ
    Cohen, AS
    SCHIZOPHRENIA BULLETIN, 2006, 32 (02) : 238 - 245
  • [49] A new Integrated Negative Symptom structure of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia using item response analysis
    Khan, Anzalee
    Lindenmayer, Jean-Pierre
    Opler, Mark
    Yavorsky, Christian
    Rothman, Brian
    Lucic, Luka
    SCHIZOPHRENIA RESEARCH, 2013, 150 (01) : 185 - 196
  • [50] Positive and negative symptoms in schizophrenia: A longitudinal analysis using latent variable structural equation modelling
    Carra, Giuseppe
    Crocamo, Cristina
    Angermeyer, Matthias
    Brugha, Traolach
    Toumi, Mondher
    Bebbington, Paul
    SCHIZOPHRENIA RESEARCH, 2019, 204 : 58 - 64